EXEL logo

EXEL
Exelixis Inc

12,196
Mkt Cap
$12.61B
Volume
1.54M
52W High
$51.63
52W Low
$33.76
PE Ratio
16.62
EXEL Fundamentals
Price
$50.15
Prev Close
$49.65
Open
$49.75
50D MA
$45.16
Beta
0.50
Avg. Volume
2.31M
EPS (Annual)
$2.78
P/B
6.57
Rev/Employee
$2.15M
$11,425.42
Loading...
Loading...

About

Exelixis, Inc.. The Group's principal activity is to develop innovative therapies for cancer and other serious diseases. Its pharmaceutical programs focuses on discovery and development of small molecule drugs for cancer. The Gruoup has built a multidisciplinary, integrated research and development platform that supports the complex, iterative nature of drug discovery, translational research and clinical development. Its first-generation anticancer product candidates in our clinical pipeline are Spectrum Selective Kinase Inhibitors, that have been optimized for balanced potency, specificity, tolerability and pharmacologic parameters. It operates in the United States.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
1,077

Frequently Asked Questions

What is Market Cap of Exelixis Inc?
What is the 52-week high for Exelixis Inc?
What is the 52-week low for Exelixis Inc?
What is Exelixis Inc stock price today?
What was Exelixis Inc stock price yesterday?
What is the PE ratio of Exelixis Inc?
What is the Price-to-Book ratio of Exelixis Inc?
What is the 50-day moving average of Exelixis Inc?
How many employees does Exelixis Inc have?

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available